Skip to main content
. 2015 Mar 2;2015:590148. doi: 10.1155/2015/590148

Figure 2.

Figure 2

Unadjusted Kaplan-Meier curves comparing survival of malignant pleural mesothelioma (MPM) patients diagnosed before and after the approval of pemetrexed as well as patients having received platinum-based chemotherapy with pemetrexed versus all other chemotherapeutic regimens.